ArticleContemporary oncology (Poznan, Poland)2012

Rituximab is highly effective for pure red cell aplasia and post-transplant lymphoproliferative disorder after unrelated hematopoietic stem cell transplantation.

Anna Kopińska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.